News Vertex Pharma makes progress in quest for non-opioid pain dr... The search for an alternative to opioid drugs for pain relief has dragged one for decades, with little success, but Vertex Pharma thinks that could be about to change. The company
News Teva will appeal opioid liability ruling in New York trial The jury in a new York trial has found that Teva Pharmaceuticals played a role in fuelling the opioid crisis in the US, and should
Partner Content Partner Content Top-Level industry professionals to speak at Pain Therapeuti... 2 weeks Pain Therapeutics Conference - expert speakers
Partner Content Partner Content Due to COVID-19, Pain Therapeutics Conference, May 2020 will... COVID-19 means Pain Therapeutics Conference is Remote
Partner Content Partner Content Chair invite Kerrie Brady & Michael Scherz released ahead of... Invite from Chairs Pain Therapeutics
News EC clears first treatment for high-risk smouldering multiple... Johnson & Johnson’s Janssen-Cilag has secured European Commission approval for a new indication of its subcutaneous formulation of DARZALEX
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face